Fresh Tracks Therapeutics 配当金
配当金 基準チェック /06
Fresh Tracks Therapeutics does not have a record of paying a dividend.
主要情報
n/a
配当利回り
-151.9%
バイバック利回り
総株主利回り | -151.9% |
将来の配当利回り | n/a |
配当成長 | n/a |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | n/a |
配当性向 | n/a |
最近の配当金アップデート
更新なし
Recent updates
Brickell Biotech changes name to Fresh Tracks Therapeutics
Sep 07Brickell Biotech GAAP EPS of -$0.01 beats by $1.43, revenue of $4.32M beats by $1.18M
Aug 11Brickell Biotech regains Nasdaq compliance for minimum bid price requirement
Jul 20Here's Why Brickell Biotech (NASDAQ:BBI) Must Use Its Cash Wisely
Feb 14Brickell Biotech Advances To Phase III As It Eyes Commercialization
May 10Brickell Biotech completes patient enrollment in late-stage sweat disorder study
Apr 27Brickell Biotech's(NASDAQ:BBI) Share Price Is Down 16% Over The Past Year.
Jan 06Brickell Biotech (BBI) Investor Presentation - Slideshow
Dec 02Brickell Bio to launch sofpironium bromide gel, 5% in Japan on November 26
Nov 18決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if FRTX's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if FRTX's dividend payments have been increasing.
配当利回り対市場
Fresh Tracks Therapeutics 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (FRTX) | n/a |
市場下位25% (US) | 1.5% |
市場トップ25% (US) | 4.5% |
業界平均 (Biotechs) | 2.2% |
アナリスト予想 (FRTX) (最長3年) | n/a |
注目すべき配当: Unable to evaluate FRTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate FRTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate FRTX's payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as FRTX has not reported any payouts.